Intraocular Lenses for Cataract Surgery
See the World
Clearly Again
Have you been diagnosed with cataracts? A cataract is a clouding of the eye’s natural lens. It’s a normal part of aging. Along with guidance from your eye care professional, the information below will help you understand your next steps.
Take a closer look at cataracts
What you should know and what you should expect as you start your journey toward a future without cataracts.
Discussing your vision options
You and your doctor have an important choice to make about the kind of cataract replacement intraocular lens (or IOL) you receive.
Take our Self-Assessment Quiz to determine which lens is right for you.
Understanding Cataract Symptoms
Be sure to discuss your symptoms with your eye care professional
With cataracts you may experience:
Experiencing any of these symptoms?
Click the button below to discover which IOL may be right for you.
What happens during cataract surgery?
Cataract surgery is an exciting opportunity to renew your vision and see life clearly again. The procedure takes and hour or less to perform.2
The surgeon removes your clouded lens and replaces it with a new, artificial lens
You’ll receive local anesthetics to numb the area around your eye and you may be given a sedative to help you relax.2
Recovery after cataract surgery is usually very quick
Within a few days most patients can return to their daily activities, with vision improving over time.2
After surgery, your doctor will monitor the healing process
Patients usually see their doctor a day or two after surgery, the following week, and then again after one month.2
Alcon’s trusted and proven IOL platform has been implanted in more than
135 million
eyes globally.3
What kind of vision would you like after surgery?
Depending on the IOL you choose (in conjunction with your surgeon), cataract surgery may also help you become less dependent on glasses, or even spectacle-free.2,4
Our gold standard in trifocal lens technology. Patients can enjoy a full range of vision without glasses.5
Allows you to see clearly at far and intermediate distances while still providing functional near vision.6 Patients may require glasses for clear near vision.6
Provides exceptional clarity for distance vision and correct astigmatism at the same time.7,9
Provides exceptional clarity for distance vision.7,8* Patients may require glasses for clear near or intermediate vision.
IMPORTANT PRODUCT INFORMATION - CLAREON® FAMILY OF IOLS
CAUTION: Federal law restricts these devices to sale by or on the order of a physician.
INDICATION: The family of Clareon® intraocular lenses (IOLs) includes the Clareon® Aspheric Hydrophobic Acrylic and Clareon® Aspheric Toric IOLs, the Clareon® PanOptix® Trifocal Hydrophobic IOL, Clareon® PanOptix® Toric, Clareon® Vivity® Extended Vision Hydrophobic Posterior Chamber IOL and Clareon® Vivity® Toric IOLs. Each of these IOLs is indicated for visual correction of aphakia in adult patients following cataract surgery. In addition, the Clareon® Toric IOLs are indicated to correct pre-existing corneal astigmatism at the time of cataract surgery. The Clareon® PanOptix® lens mitigates the effects of presbyopia by providing improved intermediate and near visual acuity, while maintaining comparable distance visual acuity with a reduced need for eyeglasses, compared to a monofocal IOL. The Clareon® Vivity® lens mitigates the effects of presbyopia by providing an extended depth of focus. Compared to an aspheric monofocal IOL, the lens provides improved intermediate and near visual acuity, while maintaining comparable distance visual acuity. All of these IOLs are intended for placement in the capsular bag.
WARNINGS / PRECAUTIONS: General cautions for all Clareon® IOLs: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting any IOL in a patient with any of the conditions described in the Directions for Use that accompany each IOL. Physicians should target emmetropia and ensure that IOL centration is achieved.
For the Clareon® Aspheric Toric, PanOptix® Toric and Vivity® Toric IOLs, the lens should not be implanted if the posterior capsule is ruptured, if the zonules are damaged, or if a primary posterior capsulotomy is planned. Rotation can reduce astigmatic correction; if necessary, lens repositioning should occur as early as possible prior to lens encapsulation.
For the Clareon® PanOptix® IOL, some visual effects may be expected due to the superposition of focused and unfocused multiple images. These may include some perceptions of halos or starbursts, as well as other visual symptoms. As with other multifocal IOLs, there is a possibility that visual symptoms may be significant enough that the patient will request explant of the multifocal IOL. A reduction in contrast sensitivity as compared to a monofocal IOL may be experienced by some patients and may be more prevalent in low lighting conditions. Therefore, patients implanted with multifocal IOLs should exercise caution when driving at night or in poor visibility conditions. Patients should be advised that unexpected outcomes could lead to continued spectacle dependence or the need for secondary surgical intervention (e.g., intraocular lens replacement or repositioning). As with other multifocal IOLs, patients may need glasses when reading small print or looking at small objects. Posterior capsule opacification (PCO), may significantly affect the vision of patients with multifocal IOLs sooner in its progression than patients with monofocal IOLs.
For the Clareon® Vivity® IOL, most patients implanted with the Vivity® IOL are likely to experience significant loss of contrast sensitivity as compared to a monofocal IOL. Therefore, it is essential that prospective patients be fully informed of this risk before giving their consent for implantation of the Clareon® Vivity® IOL. In addition, patients should be warned that they will need to exercise caution when engaging in activities that require good vision in dimly lit environments, such as driving at night or in poor visibility conditions, especially in the presence of oncoming traffic. It is possible to experience very bothersome visual disturbances, significant enough that the patient could request explant of the IOL. In the parent AcrySof® IQ Vivity® IOL clinical study, 1% to 2% of AcrySof® IQ Vivity® IOL patients reported very bothersome starbursts, halos, blurred vision, or dark area visual disturbances; however, no explants were reported. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure available from Alcon informing them of possible risks and benefits associated with these IOLs.
ATTENTION: Reference the Directions for Use labeling for each IOL for a complete listing of indications, warnings and precautions.
REFERENCES:
- Cataract Surgery. Mayo Clinic web page. https://www.mayoclinic.org/tests-procedures/cataract-surgery/about/pac-20384765. Accessed March 8, 2023.
- Mayo Clinic Staff. What you can expect [Cataract Surgery]. Mayo Clinic. http://www.mayoclinic.org/tests-procedures/cataract-surgery/basics/what-you-can-expect/prc-20012917. Updated July 30, 2013. Accessed August 20, 2018.
- Alcon Data on File, 2020.
- terHorst C. American Academy of Ophthalmology (AAO). “Choosing an Artificial Lens for Cataract Surgery.” https://www.aao.org/eye-health/treatments/best-artificial-lens-IOL-cataract-surgery. Accessed November 1, 2021.
- Clareon® PanOptix® Trifocal Hydrophobic Acrylic IOL Model CNWTT0 Directions for Use.
- Clareon® Vivity® Extended Vision Hydrophobic IOL (CNWET0) Directions for Use.
- Werner L, Thatthamla I, Ong M, et al. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL. J Cataract Refract Surg. 2019;45:1490-1497.
- Oshika T, Fujita Y, Inamura M, Miyata K. Mid-term and long-term clinical assessments of a new 1-piece hydrophobic acrylic IOL with hydroxyethyl-methacrylate. J Cataract Refract Surg. 2020 May;46(5):682-687.
- Clareon® Toric Directions for Use.
